Results regarding the inhibitory effect of hinokitiol in BMI1 expression through the induction of miR-494-3p suggest that hinokitiol has the potential to develop into a sensitization agent in breast cancer radiotherapy. This evidence concerns the gene BMI1 and breast carcinoma.